Event

CFA 2025 Annual General Meeting

The Canadian Fabry Association hereby gives notice of its annual general meeting.

News

Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Sangamo expects to complete Biological License Application (BLA) submission under accelerated approval pathway in second quarter of 2026

Event

Alberta (Canmore) Patient empowerment meeting and Youth & young adult summit

Our Patient empowerment meeting, and our Youth & Young adult summit will be in Canmore, Alberta this year.